Compare BLCO & RGTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | RGTI |
|---|---|---|
| Founded | 1853 | 2013 |
| Country | Canada | United States |
| Employees | N/A | 164 |
| Industry | Ophthalmic Goods | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.9B |
| IPO Year | 2022 | N/A |
| Metric | BLCO | RGTI |
|---|---|---|
| Price | $15.80 | $25.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | $18.45 | ★ $30.78 |
| AVG Volume (30 Days) | 469.3K | ★ 33.1M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,101,000,000.00 | N/A |
| Revenue This Year | $8.65 | $225.06 |
| Revenue Next Year | $5.59 | $99.56 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $11.22 | $10.71 |
| 52 Week High | $18.92 | $58.15 |
| Indicator | BLCO | RGTI |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | 67.00 |
| Support Level | $15.67 | $21.59 |
| Resistance Level | $16.41 | $26.96 |
| Average True Range (ATR) | 0.38 | 2.12 |
| MACD | -0.00 | 0.67 |
| Stochastic Oscillator | 18.00 | 78.22 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Rigetti Computing Inc builds quantum computers and the superconducting quantum processors that power them. The Company sells 9-qubit to 108-qubit quantum computing systems under the Novera and Cepheus trade names. Through the Rigetti Quantum Cloud Services (QCS) platform, the Company's machines can be integrated into any public, private or hybrid cloud. The Company also operates in Fremont, California; London, United Kingdom; Adelaide, Australia; British Columbia, Canada and Mumbai, India. The Company's revenue is derived from operations in the United States and the United Kingdom.